{
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "ucits": true,
    "type": "ETP",
    "complex_factors": "Leverage, Derivatives, Synthetic Replication, Compounding Effect, Roll Costs, High Risk Profile",
    "classification": "complex",
    "supporting_data": "The product is a leveraged ETP (not a UCITS ETF) providing 2x daily exposure to the FTSE 100 via futures contracts, with returns reset daily, leading to a compounding effect that deviates from simple 2x the index over periods longer than one day. The use of futures (derivatives) is central to the strategy, not merely for efficient portfolio management. The product carries the highest risk indicator (7/7), explicitly warns retail investors that it 'is not simple and may be difficult to understand,' and is intended only for informed investors familiar with leveraged products. The structure involves daily rolling of futures, introducing roll costs and potential contango/backwardation effects, which are complex concepts for the average retail investor. Despite being UCITS eligible and fully collateralised, the central role of derivatives, daily leverage reset, and associated risks (including counterparty risk via the issuer) mean the product does not meet the criteria for 'non-complex' under MiFID II Article 57. The productu2019s complexity is further underscored by the explicit comprehension warning in its KID, though this is not a MiFID II requirement per se, it reflects the manufactureru2019s assessment of complexity."
}